Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 公共衛生碩士學位學程
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/90292
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor方啓泰zh_TW
dc.contributor.advisorChi-Tai Fangen
dc.contributor.author牛光宇zh_TW
dc.contributor.authorKuang-Yu Niuen
dc.date.accessioned2023-09-26T16:07:40Z-
dc.date.available2023-11-09-
dc.date.copyright2023-09-26-
dc.date.issued2023-
dc.date.submitted2023-08-02-
dc.identifier.citation1. Yuce M, Filiztekin E, Ozkaya KG. COVID-19 diagnosis -A review of current methods. Biosens Bioelectron. 2021;172:112752.
2. Lai CKC, Lam W. Laboratory testing for the diagnosis of COVID-19. Biochem Biophys Res Commun. 2021;538:226-30.
3. Dinnes J, Sharma P, Berhane S, van Wyk SS, Nyaaba N, Domen J, et al. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. The Cochrane database of systematic reviews. 2022;7(7):CD013705.
4. Jian MJ, Perng CL, Chung HY, Chang CK, Lin JC, Yeh KM, et al. Clinical assessment of SARS-CoV-2 antigen rapid detection compared with RT-PCR assay for emerging variants at a high-throughput community testing site in Taiwan. International journal of infectious diseases. 2022;115:30-4.
5. Tsai SC, Lee WS, Chen PY, Hung SH. Real world clinical performance of SARS-CoV-2 rapid antigen tests in suspected COVID-19 cases in Taiwan. J Formos Med Assoc. 2021;120(11):2042-3.
6. Cheng CC, Liu CC, Chiu TF, Shiou-Sheng Chen S. Evaluation of a Rapid Antigen Test for the Diagnosis of SARS-CoV-2 during the COVID-19 Pandemic. INQUIRY. 2022:59:1-5.
7. Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, et al. Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples. Clinical infectious diseases. 2020;71(10):2663-6.
8. La Scola B, Le Bideau M, Andreani J, Hoang VT, Grimaldier C, Colson P, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020;39(6):1059-61.
9. Gniazdowski V, Paul Morris C, Wohl S, Mehoke T, Ramakrishnan S, Thielen P, et al. Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds. Clinical infectious diseases. 2021;73(4):e860-e9.
10. Perera R, Tso E, Tsang OTY, Tsang DNC, Fung K, Leung YWY, et al. SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease. Emerg Infect Dis. 2020;26(11):2701-4.
11. Wolfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Muller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581(7809):465-9.
12. Sia SF, Yan LM, Chin AWH, Fung K, Choy KT, Wong AYL, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583(7818):834-8.
13. McKay SL, Tobolowsky FA, Moritz ED, Hatfield KM, Bhatnagar A, LaVoie SP, et al. Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak. Annals of Internal Medicine. 2021;174(7):945-51.
14. Hodges E, Lefferts B, Bates E, Desnoyers C, Bruden D, Bruce M, et al. Use of Rapid Antigen Testing for SARS-CoV-2 in Remote Communities - Yukon-Kuskokwim Delta Region, Alaska, September 15, 2020-March 1, 2021. MMWR Morbidity and mortality weekly report. 2021;70(33):1120-3.
15. Linka K, Peirlinck M, Sahli Costabal F, Kuhl E. Outbreak dynamics of COVID-19 in Europe and the effect of travel restrictions. Comput Methods Biomech Biomed Engin. 2020;23(11):710-7.
16. Ali M, Khan DM, Aamir M, Khalil U, Khan Z. Forecasting COVID-19 in Pakistan. PLoS One. 2020;15(11):e0242762.
17. ArunKumar KE, Kalaga DV, Sai Kumar CM, Chilkoor G, Kawaji M, Brenza TM. Forecasting the dynamics of cumulative COVID-19 cases (confirmed, recovered and deaths) for top-16 countries using statistical machine learning models: Auto-Regressive Integrated Moving Average (ARIMA) and Seasonal Auto-Regressive Integrated Moving Average (SARIMA). Appl Soft Comput. 2021;103:107161.
18. Lee DH, Kim YS, Koh YY, Song KY, Chang IH. Forecasting COVID-19 Confirmed Cases Using Empirical Data Analysis in Korea. Healthcare. 2021, 9, 254.
19. Maleki M, Mahmoudi MR, Wraith D, Pho KH. Time series modelling to forecast the confirmed and recovered cases of COVID-19. Travel Med Infect Dis. 2020;37:101742.
20. Qi H, Xiao S, Shi R, Ward MP, Chen Y, Tu W, et al. COVID-19 transmission in Mainland China is associated with temperature and humidity: A time-series analysis. Sci Total Environ. 2020;728:138778.
21. Vokó Z, Pitter JG. The effect of social distance measures on COVID-19 epidemics in Europe: an interrupted time series analysis. Geroscience. 2020;42(4):1075-82.
22. Yang Q, Wang J, Ma H, Wang X. Research on COVID-19 based on ARIMA model(Delta)-Taking Hubei, China as an example to see the epidemic in Italy. J Infect Public Health. 2020;13(10):1415-8.
23. Sakai-Tagawa Y, Yamayoshi S, Halfmann PJ, Wilson N, Bobholz M, Vuyk WC, et al. Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2. J Med Virol. 2023;95(5):e28788.
24. Puyskens A, Bayram F, Sesver A, Michel J, Krause E, Bourquain D, et al. Performance of 20 rapid antigen detection tests to detect SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variants using a clinical specimen panel from January 2022, Berlin, Germany. Euro Surveillance. 2023;28(16).
25. Bornemann L, Kaup O, Kleideiter J, Ruprecht B, Hoyer A, Panning M, et al. Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern. Clinical Microbiology and Infection. 2023 29(8).
-
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/90292-
dc.description.abstract背景
2021年5月台灣爆發第一波新冠病毒感染疫情,黃金診斷標準核酸檢測昂貴耗時且量能不足,醫療照護機構開始使用抗原快篩作為診斷新冠病毒感染參考,政府開設應用抗原快篩的社區篩檢站,然而台灣缺乏本土快篩試劑於真實臨床情境使用下的診斷表現資料,而抗原快篩應用於社區篩檢站的角色與效果尚待研究。

方法
本研究利用台灣北部兩個體系五間醫院於2021年5月至10月間病患抗原快篩與核酸檢測配對資料,研究抗原快篩臨床使用診斷效力,以及其陽性預測值隨疫情階段改變的變化,並分析抗原快篩偽陰性之核酸檢測CT值與抗原快篩真陽性之差異。本研究同時分析該波疫情中社區篩檢站之每日檢驗工具陽性率數據,分析檢驗陽性率不同延遲值與每日病例數之相關性,並建立病例數之線性預測模型。

結果
全研究區間45,735 對同日採檢抗原快篩與核酸檢測配對結果中,抗原快篩診斷表現敏感度為0.552、特異度0.995、陽性預測值0.614、陰性預測值0.994、診斷勝率為258.30;抗原快篩陽性預測值由疫情成長期的0.653降低至低度流行期的0.026,抗原快篩陽性之核酸檢測CT值顯著較抗原快篩偽陰性組低。 本研究發現社區快篩站檢驗陽性率與每日病例數高度相關且顯示出領先趨勢,抗原篩檢陽性率較核酸檢測陽性率率先反應病例數變化,而陽性率線性模式是預測病例數之良好模型。

結論
新冠病毒抗原快篩為一低敏感度,高特異度的檢測,臨床上無法取代核酸檢測用以診斷新冠病毒感染。雖然敏感度低,但是抗原快篩陽性代表病患病毒量高,傳染性較強。社區篩檢站使用快篩做大規模篩檢,除了迅速找出感染者以執行個人防疫措施之外,篩檢站檢測陽性率是疫情變化的領先趨勢指標。
zh_TW
dc.description.abstractBackground
Real-time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) detecting the RNA of SARS-CoV-2 is the gold standard for the diagnosis of COVID-19 disease. However, it is expensive, labor, and time-consuming. During the first wave of the Covid outbreak in May of 2021 in Taiwan, healthcare providers started utilizing SARS-CoV-2 antigen rapid tests (RAT) as a diagnostic tool to facilitate COVID-19 diagnosis, and the government activated the RAT-based mass screening program in the community. Although the RAT is used enormously in daily clinical practice, the diagnostic performance of RAT in clinical settings is lacking. And the role of RAT as a mass screening tool in community Covid screening program is not yet studied.

Methods
We analyzed Covid RAT and RT-PCR paired results from the 1st of May to the 31st of October in 2021 from five branch hospitals of two hospital systems in northern Taiwan. The duration of enrollment included the whole Covid-19 outbreak period. Using RT-PCR as the gold standard, we calculated the sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic odds ratio, regarding different outbreak stages. The cycle threshold value (CT value) from RT-PCR-diagnosed COVID-19 patients was compared between RAT positive (true positive) group and RAT negative (false negative) group. Using the daily test outputs from the4 largest community screening stations near the outbreak center, we calculated the Pearson correlation coefficient between the 3-day moving average of the nationwide COVID-19 case number and the plus to minus seven days lag value of the polled 3-day positivity rate.

Results
We examined 45,735 RAT and RT-PCR paired results during the 6-month study period. The sensitivity of RAT compared to RT-PCR is 0.552, specificity 0.995, positive predictive value 0.614, negative predictive value 0.994, and diagnostic odds ratio 258.30. The RAT positive predictive value decreased from 0.653 to less than 0.026 as the outbreak was controlled. The median RT-PCR CT value of the RAT-positive group is significantly lower than that of the RAT-negative group (p-value < 0.0001). The positivity rate output from community screening stations is strongly associated with the number of confirmed cases, with the LAG3 of the RAT positivity rate yielding the highest Pearson correlation (r=0.9683).

Conclusion
SARS-CoV-2 rapid antigen tests are specific but not adequately sensitive to exclude the diagnosis of COVID-19. Although its sensitivity is not satisfactory, COVID-19 patients with negative RAT results generally carry lower viral load and are less contagious. In addition to individual diagnostic value, the daily positive rate output from the RAT-based community screening program is a leading indicator of outbreak trend and a good predictor of case number.
en
dc.description.provenanceSubmitted by admin ntu (admin@lib.ntu.edu.tw) on 2023-09-26T16:07:40Z
No. of bitstreams: 0
en
dc.description.provenanceMade available in DSpace on 2023-09-26T16:07:40Z (GMT). No. of bitstreams: 0en
dc.description.tableofcontents碩士論文審訂書 I
致謝 II
中文摘要 III
英文摘要 V
目錄 VIII
圖目錄 X
表目錄 XI
第一章 導論 1
第一節 實習單位特色與實習之過程 1
第二節 研究架構與假設 2
第三節 文獻回顧 4
第一項 新冠病毒抗原快篩診斷表現 4
第二項 抗原快篩與新冠病毒傳染性 5
第三項 抗原快篩於社區篩檢站之防疫角色 7
第四項 社區篩檢站篩檢陽性率之流行病學意義 7
第四節 研究目的與研究問題 8
第二章 研究方法 10
第一節 研究設計 10
第二節 研究期間 10
第三節 疫情爆發區間定義 10
第四節 資料收錄範疇條件 10
第一項 新冠病毒抗原快篩診斷表現 10
第二項 社區篩檢站檢驗陽性率分析 11
第五節 統計方法 12
第一項 新冠病毒抗原快篩診斷表現 12
第二項 抗原快篩與新冠病毒傳染性 12
第三項 社區篩檢站篩檢陽性率分析 12
第三章 結果 14
第一節 研究族群 14
第一項 新冠病毒抗原快篩診斷表現 14
第二項 社區篩檢站檢驗陽性率分析 14
第二節 研究結果 15
第一項 新冠病毒抗原快篩診斷表現 15
第二項 抗原快篩與新冠病毒傳染性 16
第三項 社區篩檢站篩檢陽性率分析 17
第四章 討論 19
第一節 新冠病毒抗原快篩之臨床應用 19
第二節 以抗原快篩進行社區感染偵測 21
第三節 研究特色與限制 22
結論 24
研究附圖 25
研究附表 32
參考文獻 37
-
dc.language.isozh_TW-
dc.title新冠病毒抗原快速篩檢的診斷表現與在疫情爆發即時監測的應用zh_TW
dc.titleDiagnostic Performance of SARS-CoV-2 Rapid Antigen Test and Its Role in Real-Time Surveillance of a COVID-19 Outbreak, Taipei, Taiwanen
dc.typeThesis-
dc.date.schoolyear111-2-
dc.description.degree碩士-
dc.contributor.oralexamcommittee趙從賢;施惟量;陳抱宇zh_TW
dc.contributor.oralexamcommitteeChung-Hsien Chaou;Wei-Liang Shih;Pao-Yu Chenen
dc.subject.keyword新冠病毒,抗原快篩診斷表現,新冠肺炎篩檢與偵測,zh_TW
dc.subject.keywordSARS-CoV-2,Rapid Antigen Test Diagnostic Performance,COVID-19 Screening and Surveillance,en
dc.relation.page40-
dc.identifier.doi10.6342/NTU202302095-
dc.rights.note同意授權(限校園內公開)-
dc.date.accepted2023-08-02-
dc.contributor.author-college公共衛生學院-
dc.contributor.author-dept公共衛生碩士學位學程-
dc.date.embargo-lift2023-12-31-
顯示於系所單位:公共衛生碩士學位學程

文件中的檔案:
檔案 大小格式 
ntu-111-2.pdf
授權僅限NTU校內IP使用(校園外請利用VPN校外連線服務)
2.59 MBAdobe PDF檢視/開啟
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved